Cargando…
Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol
Elevated basal insulin secretion under fasting conditions together with insufficient stimulated insulin release is an important hallmark of type 2 diabetes, but the mechanisms controlling basal insulin secretion remain unclear. Membrane rafts exist in pancreatic islet cells and spatially organize me...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045496/ https://www.ncbi.nlm.nih.gov/pubmed/27533789 http://dx.doi.org/10.1210/me.2016-1023 |
_version_ | 1782457129489137664 |
---|---|
author | Nagaraj, Vini Kazim, Abdulla S. Helgeson, Johan Lewold, Clemens Barik, Satadal Buda, Pawel Reinbothe, Thomas M. Wennmalm, Stefan Zhang, Enming Renström, Erik |
author_facet | Nagaraj, Vini Kazim, Abdulla S. Helgeson, Johan Lewold, Clemens Barik, Satadal Buda, Pawel Reinbothe, Thomas M. Wennmalm, Stefan Zhang, Enming Renström, Erik |
author_sort | Nagaraj, Vini |
collection | PubMed |
description | Elevated basal insulin secretion under fasting conditions together with insufficient stimulated insulin release is an important hallmark of type 2 diabetes, but the mechanisms controlling basal insulin secretion remain unclear. Membrane rafts exist in pancreatic islet cells and spatially organize membrane ion channels and proteins controlling exocytosis, which may contribute to the regulation of insulin secretion. Membrane rafts (cholesterol and sphingolipid containing microdomains) were dramatically reduced in human type 2 diabetic and diabetic Goto-Kakizaki (GK) rat islets when compared with healthy islets. Oxidation of membrane cholesterol markedly reduced microdomain staining intensity in healthy human islets, but was without effect in type 2 diabetic islets. Intriguingly, oxidation of cholesterol affected glucose-stimulated insulin secretion only modestly, whereas basal insulin release was elevated. This was accompanied by increased intracellular Ca(2+) spike frequency and Ca(2+) influx and explained by enhanced single Ca(2+) channel activity. These results suggest that the reduced presence of membrane rafts could contribute to the elevated basal insulin secretion seen in type 2 diabetes. |
format | Online Article Text |
id | pubmed-5045496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Endocrine Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-50454962016-10-18 Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol Nagaraj, Vini Kazim, Abdulla S. Helgeson, Johan Lewold, Clemens Barik, Satadal Buda, Pawel Reinbothe, Thomas M. Wennmalm, Stefan Zhang, Enming Renström, Erik Mol Endocrinol Original Research Elevated basal insulin secretion under fasting conditions together with insufficient stimulated insulin release is an important hallmark of type 2 diabetes, but the mechanisms controlling basal insulin secretion remain unclear. Membrane rafts exist in pancreatic islet cells and spatially organize membrane ion channels and proteins controlling exocytosis, which may contribute to the regulation of insulin secretion. Membrane rafts (cholesterol and sphingolipid containing microdomains) were dramatically reduced in human type 2 diabetic and diabetic Goto-Kakizaki (GK) rat islets when compared with healthy islets. Oxidation of membrane cholesterol markedly reduced microdomain staining intensity in healthy human islets, but was without effect in type 2 diabetic islets. Intriguingly, oxidation of cholesterol affected glucose-stimulated insulin secretion only modestly, whereas basal insulin release was elevated. This was accompanied by increased intracellular Ca(2+) spike frequency and Ca(2+) influx and explained by enhanced single Ca(2+) channel activity. These results suggest that the reduced presence of membrane rafts could contribute to the elevated basal insulin secretion seen in type 2 diabetes. Endocrine Society 2016-10 2016-08-17 /pmc/articles/PMC5045496/ /pubmed/27533789 http://dx.doi.org/10.1210/me.2016-1023 Text en http://creativecommons.org/licenses/by-nc/4.0/ This article is published under the terms of the Creative Commons Attribution-Non Commercial License (CC-BY-NC; http://creativecommons.org/licenses/by-nc/4.0/). |
spellingShingle | Original Research Nagaraj, Vini Kazim, Abdulla S. Helgeson, Johan Lewold, Clemens Barik, Satadal Buda, Pawel Reinbothe, Thomas M. Wennmalm, Stefan Zhang, Enming Renström, Erik Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol |
title | Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol |
title_full | Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol |
title_fullStr | Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol |
title_full_unstemmed | Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol |
title_short | Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol |
title_sort | elevated basal insulin secretion in type 2 diabetes caused by reduced plasma membrane cholesterol |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045496/ https://www.ncbi.nlm.nih.gov/pubmed/27533789 http://dx.doi.org/10.1210/me.2016-1023 |
work_keys_str_mv | AT nagarajvini elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol AT kazimabdullas elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol AT helgesonjohan elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol AT lewoldclemens elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol AT bariksatadal elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol AT budapawel elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol AT reinbothethomasm elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol AT wennmalmstefan elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol AT zhangenming elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol AT renstromerik elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol |